Helen Tesfaye

720 total citations
24 papers, 199 citations indexed

About

Helen Tesfaye is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Helen Tesfaye has authored 24 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Helen Tesfaye's work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (4 papers). Helen Tesfaye is often cited by papers focused on Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (4 papers). Helen Tesfaye collaborates with scholars based in United States, Germany and Canada. Helen Tesfaye's co-authors include Elisabetta Patorno, Sebastian Schneeweiß, Deborah J. Wexler, Julie M. Paik, Heidi Zakoul, Geetha Iyer, Katsiaryna Bykov, Joshua J. Gagne, Nazleen F. Khan and Ajinkya Pawar and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Diabetes Care.

In The Last Decade

Helen Tesfaye

22 papers receiving 197 citations

Peers

Helen Tesfaye

EDM

CCM

SURGE

PRM

Ioannis Leontsinis Greece

Claudia Zemmrich Germany

Kevin M. Wheelock United States

Shunsuke Kiuchi Japan

Hayriye Esra Ataoğlu Türkiye

Daan J.L. van Twist Netherlands

Ali Usmani United States

Jaime Sanz‐Cánovas Spain

Jiří Plášek Czechia

Abraham Oomman India

Ioannis Leontsinis Greece

Helen Tesfaye

94 ×1.0

EDM

174 ×4.7

CCM

48 ×1.3

65 ×1.8

SURGE

30 ×0.9

PRM

Citations per year, relative to Helen Tesfaye Helen Tesfaye (= 1×) peers Ioannis Leontsinis

Countries citing papers authored by Helen Tesfaye

Since Specialization

Citations

This map shows the geographic impact of Helen Tesfaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Tesfaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Tesfaye more than expected).

Fields of papers citing papers by Helen Tesfaye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Tesfaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Tesfaye. The network helps show where Helen Tesfaye may publish in the future.

Co-authorship network of co-authors of Helen Tesfaye

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Tesfaye. A scholar is included among the top collaborators of Helen Tesfaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Tesfaye. Helen Tesfaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paik, Julie M., et al.. (2025). Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes. Diabetes Care. 48(12). 2127–2137.

Hansrivijit, Panupong, Helen Tesfaye, Deborah J. Wexler, et al.. (2025). Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States. Journal of Clinical Medicine. 14(2). 651–651. 3 indexed citations

Tesfaye, Helen, Julie M. Paik, Deborah J. Wexler, et al.. (2025). GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population‐based study. Diabetes Obesity and Metabolism. 28(2). 1517–1528. 1 indexed citations

Bea, Sungho, Geetha Iyer, Dae‐Hyun Kim, et al.. (2025). Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Venous Thromboembolism. JAMA Internal Medicine. 185(7). 837–837. 1 indexed citations

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2024). Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia. 67(7). 1328–1342. 8 indexed citations

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2024). Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovascular Diabetology. 23(1). 57–57. 14 indexed citations

Tesfaye, Helen, Luke E. Zabotka, Deborah J. Wexler, et al.. (2024). Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study. Journal of General Internal Medicine. 39(10). 1870–1879. 3 indexed citations

Suissa, Samy, Sebastian Schneeweiß, William B. Feldman, Helen Tesfaye, & Shirley Wang. (2024). Emulating randomized trials by observational database studies: the RCT-DUPLICATE initiative in COPD and asthma. American Journal of Epidemiology. 194(5). 1152–1159. 2 indexed citations

Najafzadeh, Mehdi, Helen Tesfaye, Sebastian Schneeweiß, et al.. (2024). Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes. Diabetes Care. 47(11). 1900–1907. 1 indexed citations

10.

Iyer, Geetha, Helen Tesfaye, Nazleen F. Khan, Heidi Zakoul, & Katsiaryna Bykov. (2023). Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020. JAMA Network Open. 6(3). e234059–e234059. 22 indexed citations

11.

Lauffenburger, Julie C., Helen Tesfaye, Daniel H. Solomon, et al.. (2023). Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA. BMJ Open. 13(11). e075840–e075840. 1 indexed citations

12.

Tesfaye, Helen, et al.. (2023). Identifying gaps and strengthening capacities for abortion research in Ethiopia: Assessment of abortion-research related experiences, skills, and interests.. PubMed. 27(8). 19–27.

13.

Roh, Miin, Helen Tesfaye, Seoyoung C. Kim, Luke E. Zabotka, & Elisabetta Patorno. (2022). Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy. Ophthalmology Retina. 6(12). 1145–1153. 1 indexed citations

14.

Lin, Kueiyu Joshua, William B. Feldman, Shirley Wang, et al.. (2022). Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies. Journal of Clinical Epidemiology. 151. 45–52. 2 indexed citations

15.

Abrahami, Devin, Helen Tesfaye, Hui Yin, et al.. (2022). Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. 45(12). 2907–2917. 23 indexed citations

16.

Pradhan, Richeek, Elisabetta Patorno, Helen Tesfaye, et al.. (2022). Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study. American Journal of Epidemiology. 191(8). 1352–1367. 17 indexed citations

17.

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2022). Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics. JAMA Network Open. 5(10). e2237606–e2237606. 25 indexed citations

18.

Pawar, Ajinkya, Joshua J. Gagne, Chandrasekar Gopalakrishnan, et al.. (2022). Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism. JAMA. 327(11). 1051–1051. 20 indexed citations

19.

Lin, Kueiyu Joshua, Sebastian Schneeweiß, Helen Tesfaye, et al.. (2020). Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity. Drugs. 80(18). 1961–1972. 23 indexed citations

20.

Tesfaye, Helen, et al.. (2008). [Hypokalaemia in a suicide attempt of an adolescent girl].. PubMed. 147(6). 333–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact